01 1Assia Chemical Industries Ltd - Teva Tech Site
02 1Bayer AG
03 1Hetero Labs Limited
04 2MSN Laboratories Private Limited
01 2Regorafenib
02 2Regorafenib Monohydrate
03 1pomalidomide
01 1Germany
02 3India
03 1Israel
NDC Package Code : 63415-0522
Start Marketing Date : 2015-08-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12527-0181
Start Marketing Date : 2024-04-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0092
Start Marketing Date : 2012-09-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0033
Start Marketing Date : 2015-02-17
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0121
Start Marketing Date : 2022-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Regorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regorafenib, including repackagers and relabelers. The FDA regulates Regorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Regorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Regorafenib supplier is an individual or a company that provides Regorafenib active pharmaceutical ingredient (API) or Regorafenib finished formulations upon request. The Regorafenib suppliers may include Regorafenib API manufacturers, exporters, distributors and traders.
click here to find a list of Regorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Regorafenib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Regorafenib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Regorafenib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Regorafenib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Regorafenib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Regorafenib suppliers with NDC on PharmaCompass.
We have 4 companies offering Regorafenib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
